120 related articles for article (PubMed ID: 28002164)
1. "Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections".
Pukšić S; Mitrović J; Morović-Vergles J
J Clin Rheumatol; 2017 Jan; 23(1):70-71. PubMed ID: 28002164
[No Abstract] [Full Text] [Related]
2. Biological agents in the management of Felty's syndrome: a systematic review.
Narváez J; Domingo-Domenech E; Gómez-Vaquero C; López-Vives L; Estrada P; Aparicio M; Martín-Esteve I; Nolla JM
Semin Arthritis Rheum; 2012 Apr; 41(5):658-68. PubMed ID: 22119104
[TBL] [Abstract][Full Text] [Related]
3. A beneficial long-term and consistent response to rituximab in the treatment of refractory neutropenia and arthritis in a patient with Felty syndrome.
Sarp U; Ataman S
J Clin Rheumatol; 2014 Oct; 20(7):398. PubMed ID: 25275774
[No Abstract] [Full Text] [Related]
4. Successful treatment of refractory neutropenia in Felty's syndrome with rituximab.
Wang CR; Chiu YC; Chen YC
Scand J Rheumatol; 2018 Jul; 47(4):340-341. PubMed ID: 28753121
[No Abstract] [Full Text] [Related]
5. [Rituximab for treatment of Felty’s syndrome].
Becker H; Appel H; Fassbinder T; Heitzmann D; Willeke P; Jacobi AM
Z Rheumatol; 2014 Jun; 73(5):465-6, 468. PubMed ID: 24659095
[TBL] [Abstract][Full Text] [Related]
6. Felty's syndrome with hyperthyroidism: a case report and literature review.
Huang T; Liu M; Xu G
Int J Rheum Dis; 2014 Jan; 17(1):122-4. PubMed ID: 24472276
[No Abstract] [Full Text] [Related]
7. Successful treatment of a large cutaneous ulcer and improvement in the hematologic manifestations of felty syndrome with rituximab.
Ayzenberg M; Shenberger KN
J Clin Rheumatol; 2014 Dec; 20(8):440-1. PubMed ID: 25417682
[No Abstract] [Full Text] [Related]
8. Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry.
Harrold LR; Reed GW; Magner R; Shewade A; John A; Greenberg JD; Kremer JM
Arthritis Res Ther; 2015 Sep; 17(1):256. PubMed ID: 26382589
[TBL] [Abstract][Full Text] [Related]
9. Parenteral gold therapy in the Felty syndrome. Experience with 20 patients.
Dillon AM; Luthra HS; Conn DL; Ferguson RH
Medicine (Baltimore); 1986 Mar; 65(2):107-12. PubMed ID: 3951357
[TBL] [Abstract][Full Text] [Related]
10. Crosby WH:What to treat in Felty's syndrome.
JAMA; 1973 Aug; 225(9):1114-5. PubMed ID: 4740616
[No Abstract] [Full Text] [Related]
11. A case of rheumatoid arthritis with Felty syndrome complicated by late-onset ankylosing spondylitis and psoriatic arthritis: a potpourri of rheumatic diseases.
Godhwani S; Gruber BL; Finzel K
J Clin Rheumatol; 2015 Jan; 21(1):53-5. PubMed ID: 25539441
[No Abstract] [Full Text] [Related]
12. Felty's Syndrome: A Qualitative Case Study.
Woolston W; Connelly LM
Medsurg Nurs; 2017 Mar; 26(2):105-9, 118. PubMed ID: 30304590
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Enselmann K; Frasnelli A
Praxis (Bern 1994); 2018 Apr; 107(8):463-466. PubMed ID: 29642792
[No Abstract] [Full Text] [Related]
14. Clinical and serologic observations on 27 patients with Felty's syndrome.
Ruderman M; Miller LM; Pinals RS
Arthritis Rheum; 1968 Jun; 11(3):377-84. PubMed ID: 5301597
[No Abstract] [Full Text] [Related]
15. Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy.
Aaltonen KJ; Joensuu JT; Virkki L; Sokka T; Aronen P; Relas H; Valleala H; Rantalaiho V; Pirilä L; Puolakka K; Uusitalo T; Blom M; Konttinen YT; Nordström D
J Rheumatol; 2015 Mar; 42(3):372-8. PubMed ID: 25593230
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
Higashida J; Wun T; Schmidt S; Naguwa SM; Tuscano JM
J Rheumatol; 2005 Nov; 32(11):2109-15. PubMed ID: 16265687
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of rituximab in Felty's syndrome.
Shipley E; Héraud A; Hennette A; Vernhes JP
Joint Bone Spine; 2008 Oct; 75(5):621-2. PubMed ID: 18805034
[No Abstract] [Full Text] [Related]
18. Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis.
Raffalli J; Wormser GP
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):231-2. PubMed ID: 27036977
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of abatacept for Felty's syndrome.
Hamada-Ode K; Taniguchi Y; Shimamura Y; Kagawa T; Terada Y
Rheumatology (Oxford); 2020 Jan; 59(1):256-259. PubMed ID: 31292638
[No Abstract] [Full Text] [Related]
20. Primary cardiac B cell lymphoma: Manifestation of Felty's syndrome or TNFα antagonist.
Benzerdjeb N; Ameur F; Ikoli JF; Sevestre H
Pathol Res Pract; 2016 Dec; 212(12):1191-1193. PubMed ID: 27773517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
